Probiotics: insights and new opportunities for Clostridioides difficile intervention
Sign Up to like & getrecommendations! Published in 2022 at "Critical Reviews in Microbiology"
DOI: 10.1080/1040841x.2022.2072705
Abstract: Abstract Clostridioides difficile infection (CDI) is a life-threatening disease caused by the Gram-positive, opportunistic intestinal pathogen C. difficile. Despite the availability of antimicrobial drugs to treat CDI, such as vancomycin, metronidazole, and fidaxomicin, recurrence of… read more here.
Keywords: clostridioides difficile; insights new; opportunities clostridioides; probiotics insights ... See more keywords